We have previously identified TRIM16 as a novel RARβ transcriptional regulator in the retinoid signal 15 and have also demonstrated that TRIM16 expression conferred retinoid sensitivity on many different retinoid-resistant cancer cell types 16. Here, RARB is linked to cancer.